{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T08:03:03Z","timestamp":1779696183331,"version":"3.53.1"},"reference-count":46,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T00:00:00Z","timestamp":1779580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Background: The reproductive toxicity of first-line antituberculosis drugs remains poorly understood, particularly when used in combination. Rifampicin, isoniazid, pyrazinamide, and ethambutol are essential in tuberculosis therapy, but their potential influence on female fertility is uncertain. This pilot study evaluated their effects, given alone or in dual, triple, and quadruple combinations, on oxidative stress, endocrine markers, and reproductive outcomes in healthy female rats. Materials and Methods: Ninety-six albino Wistar-type female rats were divided into sixteen groups of six animals each and treated with single, dual, triple, or quadruple regimens of first-line antituberculosis drugs for 28 days. After treatment, two sexually mature males were introduced per group, and therapy continued for seven additional days. Serum malondialdehyde (MDA), total glutathione (tGSH), prolactin, and anti-Mullerian hormone (AMH) levels were measured, and fertility outcomes were evaluated. Results: In single-drug groups, MDA increased and tGSH decreased, but detectable infertility was not recorded. Prolactin remained stable except in the pyrazinamide group, where it declined. Dual-drug regimens increased oxidative imbalance; fertility failure occurred only in pyrazinamide-lacking groups and was accompanied by higher prolactin and lower AMH. Triple and quadruple combinations produced prominent oxidative imbalance. In triple-drug regimens, infertility was lower in pyrazinamide-containing groups than in the pyrazinamide-free group, but this pattern was not maintained in the quadruple regimen. Fertility impairment was not consistently aligned with the degree of oxidative stress and may involve prolactin and AMH alterations. Conclusions: These findings suggest that reproductive impairment under these experimental conditions may involve endocrine alterations and cannot be explained solely by serum oxidative imbalance. Pyrazinamide-associated fertility preservation appeared context-dependent and requires further confirmation in larger mechanistic studies with broader reproductive and endocrine assessment.<\/jats:p>","DOI":"10.3390\/life16060878","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T06:42:18Z","timestamp":1779691338000},"page":"878","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pilot Study on the Effects of First-Line Antituberculosis Drugs and Their Combinations on Selected Reproductive Endpoints in Female Rats"],"prefix":"10.3390","volume":"16","author":[{"given":"Elif Esra","family":"Uyar","sequence":"first","affiliation":[{"name":"Department of In Vitro Fertilization, Clinic of Gynecology and Obstetrics, Lokman Hekim Istanbul Hospital, Istanbul 34912, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7576-0678","authenticated-orcid":false,"given":"Bulent","family":"Yavuzer","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Erzincan Binali Y\u0131ld\u0131r\u0131m University, Erzincan 24100, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5109-7052","authenticated-orcid":false,"given":"Mansura","family":"Babayeva","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 2, Azerbaijan Medical University, Baku AZ1022, Azerbaijan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5431-111X","authenticated-orcid":false,"given":"Nurinisa","family":"Yucel","sequence":"additional","affiliation":[{"name":"Pharmacy Services Program, Vocational School of Health Services, Erzincan Binali Y\u0131ld\u0131r\u0131m University, Erzincan 24036, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Gunay","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Faculty of Medicine, Erzincan Binali Y\u0131ld\u0131r\u0131m University, Erzincan 24100, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9239-4099","authenticated-orcid":false,"given":"Halis","family":"Suleyman","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Erzincan Binali Y\u0131ld\u0131r\u0131m University, Erzincan 24100, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,24]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2025). Global Tuberculosis Report 2025, World Health Organization."},{"key":"ref_2","unstructured":"Padda, I.S., and Muralidhara, R.K. (2023). Antitubercular Medications. StatPearls, StatPearls Publishing."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2161-1068.1000209","DOI":"10.4172\/2161-1068.1000209","article-title":"Current Overview of Anti-Tuberculosis Drugs: Metabolism and Toxicities","volume":"6","author":"Sarkar","year":"2016","journal-title":"Mycobact. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/1753465813503028","article-title":"Treatment of latent tuberculosis infection","volume":"7","author":"Parekh","year":"2013","journal-title":"Ther. Adv. Respir. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"27988","DOI":"10.1038\/s41598-025-11949-0","article-title":"RpoB mutation patterns in Rifampicin-resistant tuberculosis: A Jiangxi Province study, 2021\u20132023","volume":"15","author":"Mao","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.meegid.2016.09.004","article-title":"Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis","volume":"45","author":"Unissa","year":"2016","journal-title":"Infect. Genet. Evol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"10770","DOI":"10.1038\/s41598-017-11503-7","article-title":"Isoniazid Killing of Mycobacterium smegmatis NADH Pyrophosphatase Mutant at Single-Cell Level using Microfluidics and Time-Lapse Microscopy","volume":"7","author":"Elitas","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_8","first-page":"1","article-title":"Mechanisms of Pyrazinamide Action and Resistance","volume":"2","author":"Zhang","year":"2013","journal-title":"Microbiol. Spectr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1128\/AAC.00162-09","article-title":"The arabinosyltransferase EmbC is inhibited by ethambutol in Mycobacterium tuberculosis","volume":"53","author":"Goude","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3201\/eid1703.101363","article-title":"Increasing drug resistance in extensively drug-resistant tuberculosis, South Africa","volume":"17","author":"Shah","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0140-6736(14)60569-9","article-title":"Causes of international increases in older age life expectancy","volume":"385","author":"Mathers","year":"2015","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.54817\/IC.v65n3a05","article-title":"Protective effects of thiamine pyrophosphate and cinnamon against oxidative liver damage induced by an isoniazid and rifampicin combination in rats","volume":"65","author":"Yeter","year":"2024","journal-title":"Investig. Clin."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.bbrc.2018.02.030","article-title":"First-line anti-tuberculosis drugs induce hepatotoxicity: A novel mechanism based on a urinary metabolomics platform","volume":"497","author":"Cao","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_14","first-page":"99","article-title":"Antifertility Potential of Isoniazid and Rifampicin in Adult Female Wistar Rats","volume":"8","author":"Ezeuko","year":"2020","journal-title":"J. Infertil. Reprod. Biol."},{"key":"ref_15","first-page":"263","article-title":"Ethambutol-induced ovarian, uterine and placental oxidative stress: Implication for reproductive outcome in female Wistar rats","volume":"23","author":"Ezeuko","year":"2024","journal-title":"Sci. Afr."},{"key":"ref_16","first-page":"285","article-title":"Pyrazinamide-mediated changes in rat type I collagen and spermatogenesis indices","volume":"68","author":"Bondarenko","year":"2011","journal-title":"Acta Pol. Pharm."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Bakare, A.A., Moses, V.Y., Beckely, C.T., Oluyemi, T.I., Ogunfeitimi, G.O., Adelaja, A.A., Ayorinde, G.T., Gbadebo, A.M., Fagbenro, O.S., and Ogunsuyi, O.I. (2022). The first-line antituberculosis drugs, and their fixed-dose combination induced abnormal sperm morphology and histological lesions in the testicular cells of male mice. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.1023413"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1071\/RD22108","article-title":"Anti-tuberculosis drugs used in a directly observed treatment short course (DOTS) schedule alter endocrine patterns and reduce the ovarian reserve and oocyte quality in the mouse","volume":"34","author":"Rao","year":"2022","journal-title":"Reprod. Fertil. Dev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1515\/jbcpp-2017-0087","article-title":"First-line antituberculosis drugs disrupt endocrine balance and induce ovarian and uterine oxidative stress in rats","volume":"29","author":"Adebayo","year":"2018","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Percie du Sert, N., Hurst, V., Ahluwalia, A., Alam, S., Avey, M.T., Baker, M., Browne, W.J., Clark, A., Cuthill, I.C., and Dirnagl, U. (2020). The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol., 18.","DOI":"10.1371\/journal.pbio.3000410"},{"key":"ref_21","first-page":"E255","article-title":"Ethical considerations regarding animal experimentation","volume":"63","author":"Kiani","year":"2022","journal-title":"J. Prev. Med. Hyg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e10660","DOI":"10.1590\/1414-431x2020e10660","article-title":"The protective effect of lycopene against oxidative kidney damage associated with combined use of isoniazid and rifampicin in rats","volume":"54","author":"Bedir","year":"2021","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Ciftel, S., Ciftel, S., Altuner, D., Huseynova, G., Yucel, N., Mendil, A.S., Sarigul, C., Suleyman, H., and Bulut, S. (2025). Effects of adenosine triphosphate, thiamine pyrophosphate, melatonin, and liv-52 on subacute pyrazinamide proliferation hepatotoxicity in rats. BMC Pharmacol. Toxicol., 26.","DOI":"10.1186\/s40360-025-00901-7"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3109\/15569527.2015.1077857","article-title":"The effect of thiamine pyrophosphate on ethambutol-induced ocular toxicity","volume":"35","author":"Cinici","year":"2016","journal-title":"Cutan. Ocul. Toxicol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2478\/v10102-012-0002-9","article-title":"Damage of testicular cell macromolecules and reproductive capacity of male rats following co-administration of ethambutol, rifampicin, isoniazid and pyrazinamide","volume":"5","author":"Shayakhmetova","year":"2012","journal-title":"Interdiscip. Toxicol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1055\/s-0040-1722535","article-title":"Adverse Drug Reactions with First-Line and Second-Line Drugs in Treatment of Tuberculosis","volume":"57","author":"Prasad","year":"2021","journal-title":"Ann. Natl. Acad. Med. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4103\/0974-1208.192050","article-title":"Effect of antitubercular treatment on ovarian function in female genital tuberculosis with infertility","volume":"9","author":"Sharma","year":"2016","journal-title":"J. Hum. Reprod. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e070456","DOI":"10.1136\/bmjopen-2022-070456","article-title":"Effects of antituberculosis treatment on pregnancy outcomes in infertile women with genital tuberculosis: A systematic review","volume":"13","author":"Tuco","year":"2023","journal-title":"BMJ Open"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.toxrep.2016.06.007","article-title":"The combined fixed-dose antituberculous drugs alter some reproductive functions with oxidative stress involvement in wistar rats","volume":"3","author":"Awodele","year":"2016","journal-title":"Toxicol. Rep."},{"key":"ref_31","first-page":"1","article-title":"Toxic effects of antituberculosis drugs (isoniazid and rifampicin) on feto-placental unit of wistar rats: A morphological, histological and biochemical study","volume":"3","author":"Ezeuk","year":"2019","journal-title":"J. Clin. Exp. Tox."},{"key":"ref_32","first-page":"151","article-title":"Role of Oxidative Stress in Antituberculous Drugs (Individuals and Combined) Cytotoxicity in Hepg2 Cells","volume":"45","author":"Elmosry","year":"2016","journal-title":"Malays. Appl. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"152749","DOI":"10.1016\/j.tox.2021.152749","article-title":"Oral isoniazid causes oxidative stress, oocyte deterioration and infertility in mice","volume":"455","author":"Qiao","year":"2021","journal-title":"Toxicology"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Meca, A.D., Turcu-Stiolica, A., Stanciulescu, E.C., Andrei, A.M., Nitu, F.M., Banita, I.M., Matei, M., and Pisoschi, C.G. (2021). Variations of Serum Oxidative Stress Biomarkers under First-Line Antituberculosis Treatment: A Pilot Study. J. Pers. Med., 11.","DOI":"10.3390\/jpm11020112"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Auriemma, R.S., Del Vecchio, G., Scairati, R., Pirchio, R., Liccardi, A., Verde, N., de Angelis, C., Menafra, D., Pivonello, C., and Conforti, A. (2020). The Interplay Between Prolactin and Reproductive System: Focus on Uterine Pathophysiology. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.594370"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Szukiewicz, D. (2024). Current Insights in Prolactin Signaling and Ovulatory Function. Int. J. Mol. Sci., 25.","DOI":"10.20944\/preprints202401.0951.v1"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Iancu, M.E., Albu, A.I., and Albu, D.N. (2023). Prolactin Relationship with Fertility and In Vitro Fertilization Outcomes-A Review of the Literature. Pharmaceuticals, 16.","DOI":"10.3390\/ph16010122"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.21037\/gpm-21-4","article-title":"Prolactin secretion in women: Narrative review","volume":"4","year":"2021","journal-title":"Gynecol. Pelvic Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4103\/0970-2113.120626","article-title":"Rifampicin induced adrenal crisis in an uncommon setting","volume":"30","author":"Ray","year":"2013","journal-title":"Lung India"},{"key":"ref_40","first-page":"e2723","article-title":"Hyperprolactinemia with Galactorrhea Due to Subclinical Hypothyroidism: A Case Report and Review of Literature","volume":"10","author":"Aziz","year":"2018","journal-title":"Cureus"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Iwase, A., Hasegawa, Y., Tsukui, Y., Kobayashi, M., Hiraishi, H., Nakazato, T., and Kitahara, Y. (2023). Anti-Mullerian hormone beyond an ovarian reserve marker: The relationship with the physiology and pathology in the life-long follicle development. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1273966"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Russell, N., Gilmore, A., and Roudebush, W.E. (2022). Clinical Utilities of Anti-Mullerian Hormone. J. Clin. Med., 11.","DOI":"10.3390\/jcm11237209"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1210\/clinem\/dgaa513","article-title":"Anti-Mullerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function","volume":"105","author":"Moolhuijsen","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_44","first-page":"1","article-title":"Effect of Female Genital Tubercular Involvement on Anti-Mullerian Hormone Secretion in Latent Genital Tuberculosis Affected Women","volume":"4","author":"Chatterjee","year":"2019","journal-title":"Reprod. Med. Gynecol. Obstet."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4103\/jhrs.jhrs_36_23","article-title":"Analysis of the Effect of Female Genital Tuberculosis on Ovarian Reserve Parameters","volume":"16","author":"Richa","year":"2023","journal-title":"J. Hum. Reprod. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/09513590.2020.1855634","article-title":"Serum anti-Mullerian hormone, prolactin and estradiol concentrations in infertile women with endometriosis","volume":"37","author":"Pedachenko","year":"2021","journal-title":"Gynecol. Endocrinol."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/16\/6\/878\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T07:15:19Z","timestamp":1779693319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/16\/6\/878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,24]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["life16060878"],"URL":"https:\/\/doi.org\/10.3390\/life16060878","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,24]]}}}